462 related articles for article (PubMed ID: 16464908)
1. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
LeBrasseur NK; Kelly M; Tsao TS; Farmer SR; Saha AK; Ruderman NB; Tomas E
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E175-81. PubMed ID: 16464908
[TBL] [Abstract][Full Text] [Related]
2. Low-intensity contraction activates the alpha1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle.
Toyoda T; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Sato K; Fushiki T; Nakao K; Hayashi T
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E583-90. PubMed ID: 16249251
[TBL] [Abstract][Full Text] [Related]
3. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
5. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
6. Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice.
Planavila A; Alegret M; Sánchez RM; Rodríguez-Calvo R; Laguna JC; Vázquez-Carrera M
Biochem Pharmacol; 2005 Apr; 69(8):1195-204. PubMed ID: 15794940
[TBL] [Abstract][Full Text] [Related]
7. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
8. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
Ye JM; Dzamko N; Hoy AJ; Iglesias MA; Kemp B; Kraegen E
Diabetes; 2006 Oct; 55(10):2797-804. PubMed ID: 17003345
[TBL] [Abstract][Full Text] [Related]
10. Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.
Lessard SJ; Chen ZP; Watt MJ; Hashem M; Reid JJ; Febbraio MA; Kemp BE; Hawley JA
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E251-7. PubMed ID: 16118254
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors gamma and alpha agonists stimulate cardiac glucose uptake via activation of AMP-activated protein kinase.
Xiao X; Su G; Brown SN; Chen L; Ren J; Zhao P
J Nutr Biochem; 2010 Jul; 21(7):621-6. PubMed ID: 19570670
[TBL] [Abstract][Full Text] [Related]
12. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P; Quartier E; Pipeleers D; Van de Casteele M
Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
[TBL] [Abstract][Full Text] [Related]
13. Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles.
Egawa T; Hamada T; Kameda N; Karaike K; Ma X; Masuda S; Iwanaka N; Hayashi T
Metabolism; 2009 Nov; 58(11):1609-17. PubMed ID: 19608206
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
16. Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMP-activated protein kinase.
Hutchinson DS; Csikasz RI; Yamamoto DL; Shabalina IG; Wikström P; Wilcke M; Bengtsson T
Cell Signal; 2007 Jul; 19(7):1610-20. PubMed ID: 17391917
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.
Saha AK; Avilucea PR; Ye JM; Assifi MM; Kraegen EW; Ruderman NB
Biochem Biophys Res Commun; 2004 Feb; 314(2):580-5. PubMed ID: 14733947
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.
Ceolotto G; Gallo A; Papparella I; Franco L; Murphy E; Iori E; Pagnin E; Fadini GP; Albiero M; Semplicini A; Avogaro A
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2627-33. PubMed ID: 17916771
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone acutely activates AMP-activated protein kinase and inhibits insulin secretion from beta cells.
Wang X; Zhou L; Shao L; Qian L; Fu X; Li G; Luo T; Gu Y; Li F; Li J; Zheng S; Luo M
Life Sci; 2007 Jun; 81(2):160-5. PubMed ID: 17544010
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.
He G; Sung YM; Digiovanni J; Fischer SM
Cancer Res; 2006 Feb; 66(3):1873-8. PubMed ID: 16452250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]